Barclays Bank PLC | Barclays | financial services | price-fixing or anti-competitive practices | 2016 | $100,000,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | $100,000,000 |
Citibank | Citigroup | financial services | price-fixing or anti-competitive practices | 2018 | $100,000,000 |
Mallinckrodt plc | Mallinckrodt | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $100,000,000 |
Merrill Lynch & Co. Inc. | Bank of America | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $100,000,000 |
Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | $102,500,000 |
Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | kickbacks and bribery | 2020 | $103,000,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | kickbacks and bribery | 2014 | $105,000,000 |
Chase Bank USA N.A. | JPMorgan Chase | financial services | consumer protection violation | 2015 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $106,000,000 |
Bayer AG | Bayer | chemicals | False Claims Act and related | 2003 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
Mylan Laboratories et al. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
Ally Financial | Ally Financial | financial services | mortgage abuses | 2012 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $109,628,425 |
Goldman Sachs | Goldman Sachs | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $110,000,000 |
Chimei Innolux Corp. | Chi Mei Corporation | chemicals | price-fixing or anti-competitive practices | 2011 | $110,273,318 |
Student Loan Xpress, Inc. | First Citizens BancShares | financial services | consumer protection violation | 2009 | $112,825,000 |
Apple Inc. | Apple Inc. | electrical and electronic equipment | consumer protection violation | 2020 | $113,000,000 |
Hartford Financial Services Group, Inc. | Hartford Financial Services | financial services | price-fixing or anti-competitive practices | 2007 | $115,000,000 |
Strong Capital Management Co. | Wells Fargo | financial services | investor protection violation | 2004 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $115,000,000 |
Sharp Corporation | Foxconn Technology Group (Hon Hai Precision Industry Company) | electrical and electronic equipment | price-fixing or anti-competitive practices | 2011 | $115,500,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | $116,860,000 |
UHS, Inc and UHS of Delaware, Inc. | Universal Health Services Inc. | healthcare services | False Claims Act and related | 2020 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $117,000,000 |
Mylan Pharmaceuticals, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2009 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000 |
Practice Fusion, Inc. | Allscripts Healthcare Solutions | information technology | kickbacks and bribery | 2020 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,600,000 |
General Motors Company | General Motors | motor vehicles | motor vehicle safety violation | 2017 | $120,000,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | $120,000,000 |
Lender Processing Services, Inc. | | | mortgage abuses | 2013 | $120,000,000 |
Maxim Healthcare Services, Inc. | Maxim Healthcare Services | miscellaneous services | False Claims Act and related | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $121,514,199 |
Tenet Healthcare Corporation | Tenet Healthcare | healthcare services | kickbacks and bribery | 2016 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $123,772,464 |
King Pharmaceuticals | Pfizer | pharmaceuticals | False Claims Act and related | 2006 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $124,000,000 |
AIM Advisors | Invesco | financial services | investor protection violation | 2004 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $125,000,000 |
Cephalon | Teva Pharmaceutical Industries | pharmaceuticals | consumer protection violation | 2016 | $125,000,000 |
Morgan Stanley | Morgan Stanley | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $125,000,000 |
Ocwen Financial Services | Ocwen Financial | financial services | mortgage abuses | 2013 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $127,300,000 |
WellCare Health Plans Inc. | Centene | healthcare services | False Claims Act and related | 2012 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $137,500,000 |
Intuit, Inc. | Intuit | information technology | consumer protection violation | 2022 | $141,000,000 |
Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | $142,494,000 |
Pershing Square Capital Management | | | investor protection violation | 2017 | $145,000,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | investor protection violation | 2017 | $145,000,000 |
Uber Technologies | Uber Technologies | miscellaneous services | privacy violation | 2018 | $148,000,000 |
Brown & Williamson Tobacco | British American Tobacco | tobacco | tobacco litigation | 2003 | $150,000,000 |
JPMorgan Chase | JPMorgan Chase | financial services | investor protection violation | 2015 | $150,000,000 |
Hikma Pharmaceuticals | Hikma Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | $150,000,000 |
McKesson Corporation | McKesson | wholesalers | False Claims Act and related | 2012 | $151,000,000 |
Par Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | $154,000,000 |
Volkswagen AG | Volkswagen | motor vehicles | environmental violation | 2017 | $157,000,000 |
Purdue Frederick Company Inc. | Purdue Pharma | pharmaceuticals | False Claims Act and related | 2007 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $160,000,000 |
SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000 |
Student CU Connect CUSO, LLC | | | consumer protection violation | 2019 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $168,000,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | $169,000,000 |
AU Optronics Corporation | AU Optronics | electrical and electronic equipment | price-fixing or anti-competitive practices | 2012 | $170,000,000 |
Zurich American Insurance Company | Zurich Insurance | financial services | price-fixing or anti-competitive practices | 2006 | $171,700,000 |
Endo Health Solution | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000 |
Equifax | Equifax | miscellaneous services | privacy violation | 2019 | $175,000,000 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | $181,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2008 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000 |
Boston Scientific Corporation | Boston Scientific Corp. | medical equipment and supplies | drug or medical equipment safety violation | 2021 | $188,600,000 |
Aon Corporation | Aon | financial services | price-fixing or anti-competitive practices | 2005 | $190,000,000 |
Warner-Lambert | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2004 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000 |
Aequitas Capital Management Inc. | | | consumer protection violation | 2017 | $192,000,000 |
Credit Suisse First Boston Corp. | UBS | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $200,000,000 |
Reckitt Benckiser Group | Reckitt Benckiser | household and personal care products | Controlled Substances Act violation | 2019 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $200,000,000 |
WellCare Health Plans Inc. | Centene | healthcare services | investor protection violation | 2010 | $200,000,000 |
Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $201,975,000 |
Duke Energy | Duke Energy | utilities and power generation | price-fixing or anti-competitive practices | 2004 | $207,500,000 |
Dish Network | DISH Network | telecommunications | privacy violation | 2020 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $210,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993 |
Deutsche Bank | Deutsche Bank | financial services | price-fixing or anti-competitive practices | 2017 | $220,000,000 |
Goldman Sachs | Goldman Sachs | financial services | toxic securities abuses | 2016 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $225,000,000 |
Janus Capital Management | Janus Henderson | financial services | investor protection violation | 2004 | $225,000,000 |
Samsung Electronics, Co., Ltd. | Samsung | diversified | price-fixing or anti-competitive practices | 2011 | $240,000,000 |
Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000 |
Serono Inc. | Merck KGaA (EMD) | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $262,000,000 |
Ranbaxy | Sun Pharmaceuticals | pharmaceuticals | drug or medical equipment safety violation | 2013 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $266,729,715 |
Prudential Equity Group | Prudential Financial | financial services | investor protection violation | 2006 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $270,000,000 |
Merck | Merck | pharmaceuticals | False Claims Act and related | 2008 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $290,000,000 |
Citigroup Inc. | Citigroup | financial services | toxic securities abuses | 2014 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $291,750,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | kickbacks and bribery | 2004 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $292,969,482 |
Indivior plc | Indivior PLC | pharmaceuticals | off-label or unapproved promotion of medical products | 2021 | $300,000,000 |
S&M Brands, Inc. | | | tobacco litigation | 2021 | $300,000,000 |
Olympus Corporation of the Americas | Olympus | electrical and electronic equipment | False Claims Act and related | 2016 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $306,000,000 |
MCI | Verizon Communications | telecommunications | tax violations | 2005 | $315,000,000 |
Ameriquest Mortgage | Citigroup | financial services | consumer protection violation | 2006 | $325,000,000 |
Invesco Funds Group | Invesco | financial services | investor protection violation | 2004 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $325,000,000 |
ITT Technical Institute and PEAKS | | | consumer protection violation | 2020 | $330,000,000 |
Pfizer, Inc. | Pfizer | pharmaceuticals | kickbacks and bribery | 2009 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $331,485,170 |
Abbott Laboratories | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $339,148,643 |
Publicis Health | | | off-label or unapproved promotion of medical products | 2024 | $350,000,000 |
Archer Daniels Midland Company | Archer Daniels Midland | agribusiness | environmental violation | 2003 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $350,900,000 |
Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456 |
Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180 |
LG Display Co., Ltd. | LG | diversified | price-fixing or anti-competitive practices | 2012 | $380,000,000 |
Google, LLC | Alphabet Inc. | information technology | privacy violation | 2022 | $391,500,000 |
Marsh and McLennan | Marsh & McLennan | financial services | investor protection violation | 2009 | $400,000,000 |
Salomon Smith Barney Inc. | Morgan Stanley | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $400,000,000 |
Reckitt Benckiser Group | Reckitt Benckiser | household and personal care products | False Claims Act and related | 2019 | $400,000,000 |
Citigroup | Citigroup | financial services | mortgage abuses | 2012 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $413,041,577 |
Williams Energy Marketing & Trading | Devon Energy | oil and gas | price-fixing or anti-competitive practices | 2002 | $417,000,000 |
Moody's Corporation | Moody's | information technology | toxic securities abuses | 2017 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $426,500,000 |
JUUL Labs | Juul Labs | tobacco | tobacco litigation | 2022 | $438,500,000 |
Apple Inc. | Apple Inc. | electrical and electronic equipment | price-fixing or anti-competitive practices | 2014 | $450,000,000 |